share_log

Piper Sandler Initiates Coverage On Viking Therapeutics With Overweight Rating, Announces Price Target of $74

Benzinga ·  Dec 2 18:48  · Ratings

Piper Sandler analyst Biren Amin initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Overweight rating and announces Price Target of $74.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment